Results 311 to 320 of about 38,122 (350)
Some of the next articles are maybe not open access.

Medical Management of Peripheral Arterial Occlusive Diseases

New England Journal of Medicine, 1953
THE treatment of the patient with peripheral arterial insufficiency is increasingly successful. During the course of the disease, however, the physician is frequently called upon to resolve problem...
openaire   +3 more sources

Haptoglobin polymorphism and peripheral arterial occlusive disease

Atherosclerosis, 1999
Haptoglobin (Hp) 2-2 phenotype is a genetic risk factor in coronary atherosclerosis. In this study, haptoglobin phenotypes were determined in 141 patients with peripheral arterial occlusive disease (PAOD) and compared to a reference population (n = 1000). The relative Hp1 allele frequency was decreased among PAOD patients (0.294 vs.
Denis Clement   +4 more
openaire   +2 more sources

ANTIPLATELET THERAPY IN PERIPHERAL OCCLUSIVE ARTERIAL DISEASE

ANZ Journal of Surgery, 2006
Background:  Antiplatelet therapy (APT) in patients with peripheral occlusive arterial disease (POAD) may reduce cardiovascular (CV) morbidity and mortality by inhibiting atherothrombosis. This article reviews the current evidence for APT in patients with stable POAD and in patients undergoing revascularization procedures for POAD.Methods:  A Medline ...
Shen Wong   +2 more
openaire   +3 more sources

Lipoprotein (a) in peripheral arterial occlusive disease.

VASA. Zeitschrift fur Gefasskrankheiten, 1994
Recent studies have shown high levels of lipoprotein (a),--Lp(a)-, an atherogenic and thrombogenic lipoprotein, are considered a risk factor for coronary heart disease. This study evaluated Lp(a) levels, as well as other lipid factors, in a group of 45 patients affected by stage II peripheral arterial occlusive disease (PAOD).
LUPATTELLI, Graziana   +7 more
openaire   +2 more sources

CT Angiography of Peripheral Arterial Occlusive Disease

Techniques in Vascular and Interventional Radiology, 2006
Lower extremity computed tomography angiography (CTA) is an effective, noninvasive, and robust imaging modality that is being used increasingly to evaluate patients with peripheral arterial occlusive disease (PAOD). It is important for vascular and interventional radiologists, and vascular surgeons to be familiar with the strengths and limitations ...
Geoffrey D. Rubin, Anne S. Chin
openaire   +3 more sources

Bioabsorbable Stenting for Peripheral Arterial Occlusive Disease

Perspectives in Vascular Surgery and Endovascular Therapy, 2006
Bioabsorbable stents offer an unproven but theoretically appealing means to address the deficiencies of current stent designs. Ideally, these stents would provide early postprocedural scaffolding support yet undergo a predictable process of reabsorption, thus removing the persistent stimulus for neointimal hyperplasia.
openaire   +3 more sources

Hyperhomocysteinaemia in Patients with Peripheral Arterial Occlusive Disease

Clinical Chemistry and Laboratory Medicine, 2001
In the Western world, cardiovascular disease is still the most common cause of death. Over the past decade it has become clear that apart from common risk factors, high concentrations of total homocysteine are relavant to the process of atherosclerosis, especially in the development of premature vascular disease.
openaire   +3 more sources

Occlusive peripheral arterial disease

Postgraduate Medicine, 1982
Occlusive peripheral arterial disease is rather easy to diagnose because of its characteristic symptoms and the ease with which the extremities and their circulation can be examined. Elevation and dependency tests give a rough but reliable estimate of the degree of ischemia, and if more objective data are desired, the systolic blood pressure index can ...
openaire   +3 more sources

Diagnosis and management of peripheral arterial occlusive disease

Current Problems in Surgery, 1973
Wesley S. Moore, F. William Blaisdell
openaire   +3 more sources

Home - About - Disclaimer - Privacy